Cogent Ev To Free Cash Flow from 2010 to 2024

COGT Stock  USD 7.76  0.08  1.02%   
Cogent Biosciences EV To Free Cash Flow yearly trend continues to be comparatively stable with very little volatility. EV To Free Cash Flow will likely drop to -2.91 in 2024. EV To Free Cash Flow is a valuation metric comparing Cogent Biosciences' enterprise value to its free cash flow, used to evaluate whether Cogent Biosciences is undervalued or overvalued. View All Fundamentals
 
EV To Free Cash Flow  
First Reported
2010-12-31
Previous Quarter
(2.77)
Current Value
(2.91)
Quarterly Volatility
1.65077255
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cogent Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 4.8 M or Selling General Administrative of 36.1 M, as well as many indicators such as Price To Sales Ratio of 12.32, Dividend Yield of 0.0 or PTB Ratio of 1.23. Cogent financial statements analysis is a perfect complement when working with Cogent Biosciences Valuation or Volatility modules.
  
Check out the analysis of Cogent Biosciences Correlation against competitors.
For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.

Latest Cogent Biosciences' Ev To Free Cash Flow Growth Pattern

Below is the plot of the Ev To Free Cash Flow of Cogent Biosciences over the last few years. It is a valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued. Cogent Biosciences' EV To Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cogent Biosciences' overall financial position and show how it may be relating to other accounts over time.
Ev To Free Cash Flow10 Years Trend
Very volatile
   Ev To Free Cash Flow   
       Timeline  

Cogent Ev To Free Cash Flow Regression Statistics

Arithmetic Mean(1.62)
Coefficient Of Variation(101.83)
Mean Deviation0.98
Median(1.88)
Standard Deviation1.65
Sample Variance2.73
Range7.5917
R-Value(0.07)
Mean Square Error2.92
R-Squared0
Significance0.81
Slope(0.02)
Total Sum of Squares38.15

Cogent Ev To Free Cash Flow History

2024 -2.91
2023 -2.77
2022 -4.45
2021 -1.91
2020 3.14
2019 0.23
2018 -1.63

About Cogent Biosciences Financial Statements

Cogent Biosciences shareholders use historical fundamental indicators, such as Ev To Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Cogent Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Cogent Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cogent Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EV To Free Cash Flow(2.77)(2.91)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cogent Stock Analysis

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.